NCT01642914

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of linaclotide compared with placebo in patients with chronic constipation (CC) and prominent abdominal bloating. This study includes an up to 3-week screening period and a 2-3 week pretreatment period. Patients who are eligible will be randomized to one of two doses of linaclotide or placebo for 12 weeks. This 12-week study will assess the effects of linaclotide on bowel movement frequency, as well as other abdominal and bowel symptoms of CC.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
487

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Aug 2012

Shorter than P25 for phase_3

Geographic Reach
2 countries

151 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 13, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 17, 2012

Completed
15 days until next milestone

Study Start

First participant enrolled

August 1, 2012

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
2.7 years until next milestone

Results Posted

Study results publicly available

April 26, 2016

Completed
Last Updated

April 26, 2016

Status Verified

March 1, 2016

Enrollment Period

9 months

First QC Date

July 13, 2012

Results QC Date

May 29, 2014

Last Update Submit

March 24, 2016

Conditions

Keywords

Chronic ConstipationAbdominal BloatingLinaclotide

Outcome Measures

Primary Outcomes (1)

  • 9/12 Week Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder

    A 9/12 Week CSBM 3+1 Responder is a patient who is a CSBM 3+1 Weekly Responder for at least 9 out of the 12 weeks of the Treatment Period. A CSBM 3+1 Weekly Responder is a patient who had a CSBM Weekly Frequency Rate that was 3 or greater and increased by 1 or more from baseline.

    12-week treatment period

Secondary Outcomes (23)

  • 9/12 Week Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder

    12-week treatment period

  • Change From Baseline in 12-Week Abdominal Bloating

    Baseline and 12-week treatment period

  • Percent Change From Baseline in 12-week Abdominal Bloating

    Baseline and 12-week treatment period

  • Percent Change From Baseline in Abdominal Bloating at Week 12

    Baseline and Week 12

  • 6/12 Week Abdominal Bloating 30% Responder

    12-week treatment period

  • +18 more secondary outcomes

Study Arms (3)

Linaclotide 290 micrograms

EXPERIMENTAL

Linaclotide 290 micrograms

Drug: Linaclotide 290 micrograms

Linaclotide 145 Micrograms

EXPERIMENTAL

Linaclotide 145 micrograms

Drug: Linaclotide 145 micrograms

Placebo

PLACEBO COMPARATOR

Matching placebo

Drug: Matching placebo

Interventions

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Linaclotide 290 micrograms

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Linaclotide 145 Micrograms

oral capsule, taken once daily each morning at least 30 minutes before breakfast

Placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has completed a colonoscopy according to the American Gastroenterological Association criteria with no clinically significant findings
  • Patient has successfully completed protocol procedures (with no clinically significant findings)
  • Patient meets protocol criteria for Chronic Constipation(CC): \< 3 bowel movements per week and reports one or more of the following symptoms for at least 12 weeks:
  • Straining during more than 25% of BMs
  • Lumpy or hard stools during more than 25% of BMs
  • Sensation of incomplete evacuation during more than 25% of BMs
  • Patient demonstrates continued chronic constipation and bloating through Pretreatment Period
  • Patient is compliant with Interactive voice response System (IVRS)

You may not qualify if:

  • Patient has a history of loose or watery stools
  • Patient has symptoms of or been diagnosed with Irritable Bowel Syndrome (IBS)
  • Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility
  • Patient has any protocol-excluded or clinically significant medical or surgical history that would limit the patient's ability to complete or participate in this clinical trial or could confound the study assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (151)

Forest Investigative Site 020

Chandler, Arizona, 85224, United States

Location

Forest Investigative Site 102

Chandler, Arizona, 85224, United States

Location

Forest Investigative Site 149

Glendale, Arizona, 85308, United States

Location

Forest Investigative Site 126

Goodyear, Arizona, 85395, United States

Location

Forest Investigative Site 018

Phoenix, Arizona, 85018, United States

Location

Forest Investigative Site 061

Phoenix, Arizona, 85020, United States

Location

Forest Investigative Site 022

Scottsdale, Arizona, 85251, United States

Location

Forest Investigative Site 079

Tucson, Arizona, 85704, United States

Location

Forest Investigative Site 071

Tucson, Arizona, 85712, United States

Location

Forest Investigative Site 135

North Little Rock, Arkansas, 72117, United States

Location

Forest Investigative Site 106

Anaheim, California, 92801, United States

Location

Forest Investigative Site 104

Laguna Hills, California, 92653, United States

Location

Forest Investigative Site 066

Mission Hills, California, 91345, United States

Location

Forest Investigative Site 095

San Carlos, California, 94070, United States

Location

Forest Investigative Site 009

San Diego, California, 92108, United States

Location

Forest Investigative Site 151

Santa Monica, California, 90404, United States

Location

Forest Investigative Site 010

Westlake Village, California, 91361, United States

Location

Forest Investigative Site 012

Boulder, Colorado, 80304, United States

Location

Forest Investigative Site 041

Colorado Springs, Colorado, 80904, United States

Location

Forest Investigative Site 045

Colorado Springs, Colorado, 80907, United States

Location

Forest Investigative Site 060

Longmont, Colorado, 80501, United States

Location

Forest Investigative Site 007

Bristol, Connecticut, 06010, United States

Location

Forest Investigative Site 153

Waterbury, Connecticut, 06708, United States

Location

Forest Investigative Site 091

Boynton Beach, Florida, 33426, United States

Location

Forest Investigative Site 047

Bradenton, Florida, 34208, United States

Location

Forest Investigative Site 042

Brooksville, Florida, 34601, United States

Location

Forest Investigative Site 133

Coral Gables, Florida, 33134, United States

Location

Forest Investigative Site 131

DeLand, Florida, 32720, United States

Location

Forest Investigative Site 051

Fort Myers, Florida, 33916, United States

Location

Forest Investigative Site 137

Inverness, Florida, 34452, United States

Location

Forest Investigative Site 114

Jacksonville, Florida, 32205, United States

Location

Forest Investigative Site 004

Jupiter, Florida, 33458, United States

Location

Forest Investigative Site 016

Kissimmee, Florida, 34741, United States

Location

Forest Investigative Site 097

Lauderdale Lakes, Florida, 33319, United States

Location

Forest Investigative Site 003

Miami, Florida, 33143, United States

Location

Forest Investigative Site 002

Miami, Florida, 33183, United States

Location

Forest Investigative Site 130

New Smyrna Beach, Florida, 32168, United States

Location

Forest Investigative Site 040

Ocala, Florida, 34471, United States

Location

Forest Investigative Site 083

Orlando, Florida, 32806, United States

Location

Forest Investigative Site 150

Oviedo, Florida, 32765, United States

Location

Forest Investigative Site 132

Port Orange, Florida, 32129, United States

Location

Forest Investigative Site 127

Seminole, Florida, 33777, United States

Location

Forest Investigative Site 087

St. Petersburg, Florida, 33709, United States

Location

Forest Investigative Site 064

Tampa, Florida, 33606, United States

Location

Forest Investigative Site 115

Zephyrhills, Florida, 33542, United States

Location

Forest Investigative Site 021

Marietta, Georgia, 30060, United States

Location

Forest Investigative Site 011

Marietta, Georgia, 30067, United States

Location

Forest Investigative Site 109

Sandy Springs, Georgia, 30328, United States

Location

Forest Investigative Site 037

Stockbridge, Georgia, 30281, United States

Location

Forest Investigative Site 023

Woodstock, Georgia, 30189, United States

Location

Forest Investigative Site 015

Idaho Falls, Idaho, 83404, United States

Location

Forest Investigative Site 122

Peoria, Illinois, 61602, United States

Location

Forest Investigative Site 043

Rockford, Illinois, 61107, United States

Location

Forest Investigative Site 107

Anderson, Indiana, 46011, United States

Location

Forest Investigative Site 117

Clive, Iowa, 50325, United States

Location

Forest Investigative Site 146

Clive, Iowa, 50325, United States

Location

Forest Investigative Site 143

Davenport, Iowa, 52807, United States

Location

Forest Investigative Site 055

Iowa City, Iowa, 52242, United States

Location

Forest Investigative Site 028

Newton, Kansas, 67114, United States

Location

Forest Investigative Site 112

Overland Park, Kansas, 66215, United States

Location

Forest Investigative Site 034

Wichita, Kansas, 67205, United States

Location

Forest Investigative Site 032

Wichita, Kansas, 67207, United States

Location

Forest Investigative Site 128

Lexington, Kentucky, 40509, United States

Location

Forest Investigative Site 134

Madisonville, Kentucky, 42431, United States

Location

Forest Investigative Site 121

Baton Rouge, Louisiana, 70809, United States

Location

Forest Investigative Site 124

Metairie, Louisiana, 70006, United States

Location

Forest Investigative Site 101

Monroe, Louisiana, 71201, United States

Location

Forest Investigative Site 058

Shreveport, Louisiana, 71101, United States

Location

Forest Investigative Site 099

Shreveport, Louisiana, 71103, United States

Location

Forest Investigative Site 062

Baltimore, Maryland, 21215, United States

Location

Forest Investigative Site 008

Chevy Chase, Maryland, 20815, United States

Location

Forest Investigative Site 014

Hagerstown, Maryland, 21742, United States

Location

Forest Investigative Site 024

Towson, Maryland, 21286, United States

Location

Forest Investigative Site 006

Boston, Massachusetts, 02135, United States

Location

Forest Investigative Site 070

Chesterfield, Michigan, 48047, United States

Location

Forest Investigative Site 145

Traverse City, Michigan, 49684, United States

Location

Forest Investigative Site 141

Jackson, Mississippi, 39202, United States

Location

Forest Investigative Site 077

Fremont, Nebraska, 68025, United States

Location

Forest Investigative Site 048

Omaha, Nebraska, 68134, United States

Location

Forest Investigative Site 052

Henderson, Nevada, 89014, United States

Location

Forest Investigative Site 080

Las Vegas, Nevada, 89121, United States

Location

Forest Investigative Site 036

Clifton, New Jersey, 07012, United States

Location

Forest Investigative Site 088

Marlton, New Jersey, 08053, United States

Location

Forest Investigative Site 033

Vineland, New Jersey, 08360, United States

Location

Forest Investigative Site 063

Albuquerque, New Mexico, 87106, United States

Location

Forest Investigative Site 093

Albuquerque, New Mexico, 87108, United States

Location

Forest Investigative Site 044

Brooklyn, New York, 11206, United States

Location

Forest Investigative Site 017

Great Neck, New York, 11021, United States

Location

Forest Investigative Site 142

Asheboro, North Carolina, 27203, United States

Location

Forest Investigative Site 094

Asheville, North Carolina, 28801, United States

Location

Forest Investigative Site 075

Boone, North Carolina, 28607, United States

Location

Forest Investigative Site 123

Chapel Hill, North Carolina, 27599-7080, United States

Location

Forest Investigative Site 140

Davidson, North Carolina, 28036, United States

Location

Forest Investigative Site 039

Fayetteville, North Carolina, 28304, United States

Location

Forest Investigative Site 031

Greensboro, North Carolina, 27403, United States

Location

Forest Investigative Site 029

Greensboro, North Carolina, 27408, United States

Location

Forest Investigative Site 078

Greensboro, North Carolina, 27408, United States

Location

Forest Investigative Site 084

Harrisburg, North Carolina, 28075, United States

Location

Forest Investigative Site 073

Hickory, North Carolina, 28601, United States

Location

Forest Investigative Site 050

Hickory, North Carolina, 28602, United States

Location

Forest Investigative Site 139

High Point, North Carolina, 27262, United States

Location

Forest Investigative Site 027

Raleigh, North Carolina, 27612, United States

Location

Forest Investigative Site 119

Statesville, North Carolina, 28625, United States

Location

Forest Investigative Site 089

Wilmington, North Carolina, 28401, United States

Location

Forest Investigative Site 074

Winston-Salem, North Carolina, 27103, United States

Location

Forest Investigative Site 025

Cincinnati, Ohio, 45242, United States

Location

Forest Investigative Site 120

Cincinnati, Ohio, 45249, United States

Location

Forest Investigative Site 056

Cleveland, Ohio, 44122, United States

Location

Forest Investigative Site 026

Columbus, Ohio, 43215, United States

Location

Forest Investigative Site 098

Dayton, Ohio, 45415, United States

Location

Forest Investigative Site 090

Dayton, Ohio, 45432, United States

Location

Forest Investigative Site 085

Mentor, Ohio, 44060, United States

Location

Forest Investigative Site 068

Wadsworth, Ohio, 44281, United States

Location

Forest Investigative Site 118

Oklahoma City, Oklahoma, 73104, United States

Location

Forest Investigative Site 081

Levittown, Pennsylvania, 19056, United States

Location

Forest Investigative Site 001

Pittsburgh, Pennsylvania, 15206, United States

Location

Forest Investigative Site 110

Reading, Pennsylvania, 19606, United States

Location

Forest Investigative Site 116

Greer, South Carolina, 29650, United States

Location

Forest Investigative Site 046

Simpsonville, South Carolina, 29681, United States

Location

Forest Investigative Site 092

Dakota Dunes, South Dakota, 57049, United States

Location

Forest Investigative Site 129

Chattanooga, Tennessee, 37421, United States

Location

Forest Investigative Site 138

Kingsport, Tennessee, 37660, United States

Location

Forest Investigative Site 125

Austin, Texas, 78756, United States

Location

Forest Investigative Site 035

Dallas, Texas, 75231, United States

Location

Forest Investigative Site 005

Dallas, Texas, 75234, United States

Location

Forest Investigative Site 111

Fort Worth, Texas, 76135, United States

Location

Forest Investigative Site 100

Houston, Texas, 77034, United States

Location

Forest Investigative Site 067

Katy, Texas, 77450, United States

Location

Forest Investigative Site 049

Pasadena, Texas, 77505, United States

Location

Forest Investigative Site 030

San Antonio, Texas, 78209, United States

Location

Forest Investigative Site 076

San Antonio, Texas, 78229, United States

Location

Forest Investigative Site 065

Sugarland, Texas, 77479, United States

Location

Forest Investigative Site 019

Ogden, Utah, 84405, United States

Location

Forest Investigative Site 105

Salt Lake City, Utah, 84107, United States

Location

Forest Investigative Site 113

Sandy City, Utah, 84094, United States

Location

Forest Investigative Site 053

Charlottesville, Virginia, 22911, United States

Location

Forest Investigative Site 108

Chesapeake, Virginia, 23320, United States

Location

Forest Investigative Site 136

Chesapeake, Virginia, 23320, United States

Location

Forest Investigative Site 148

Christiansburg, Virginia, 24073, United States

Location

Forest Investigative Site 072

Lynchburg, Virginia, 24502, United States

Location

Forest Investigative Site 069

Newport News, Virginia, 23606, United States

Location

Forest Investigative Site 013

Norfolk, Virginia, 23502, United States

Location

Forest Investigative Site 038

Richmond, Virginia, 23294, United States

Location

Forest Investigative Site 103

Spokane, Washington, 99208, United States

Location

Forest Investigative Site 082

La Crosse, Wisconsin, 54601, United States

Location

Forest Investigative Site 096

Milwaukee, Wisconsin, 53215, United States

Location

Forest Investigative Site 054

Greater Sudbury, Ontario, P3E 1H5, Canada

Location

Forest Investigative Site 059

Sarnia, Ontario, N7T 4X3, Canada

Location

Forest Investigative Site 086

Toronto, Ontario, M4S 1Y2, Canada

Location

Forest Investigative Site 147

Toronto, Ontario, M9W 4L6, Canada

Location

Forest Investigative Site 152

Vaughan, Ontario, L4L 4Y7, Canada

Location

Related Publications (2)

  • Lacy BE, Shea EP, Manuel M, Abel JL, Jiang H, Taylor DCA. Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. PLoS One. 2021 Jan 11;16(1):e0243318. doi: 10.1371/journal.pone.0243318. eCollection 2021.

  • Lacy BE, Schey R, Shiff SJ, Lavins BJ, Fox SM, Jia XD, Blakesley RE, Hao X, Cronin JA, Currie MG, Kurtz CB, Johnston JM, Lembo AJ. Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial. PLoS One. 2015 Jul 29;10(7):e0134349. doi: 10.1371/journal.pone.0134349. eCollection 2015.

MeSH Terms

Conditions

Constipation

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Steven Shiff, Executive Director, Clinical Development
Organization
Forest Research Institute

Study Officials

  • Steven Shiff, MD

    Forest Laboratories

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2012

First Posted

July 17, 2012

Study Start

August 1, 2012

Primary Completion

May 1, 2013

Study Completion

August 1, 2013

Last Updated

April 26, 2016

Results First Posted

April 26, 2016

Record last verified: 2016-03

Locations